• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

睾丸混合性生殖细胞肿瘤:一项使用干细胞标志物OCT3/4、SOX2和GDF3的形态学和免疫组织化学研究,重点关注形态学上难以分类的区域。

Testicular mixed germ cell tumors: a morphological and immunohistochemical study using stem cell markers, OCT3/4, SOX2 and GDF3, with emphasis on morphologically difficult-to-classify areas.

作者信息

Gopalan Anuradha, Dhall Deepti, Olgac Semra, Fine Samson W, Korkola James E, Houldsworth Jane, Chaganti Raju S, Bosl George J, Reuter Victor E, Tickoo Satish K

机构信息

Department of Pathology, Memorial Sloan Kettering Cancer Center, New York, NY 10065, USA.

出版信息

Mod Pathol. 2009 Aug;22(8):1066-74. doi: 10.1038/modpathol.2009.66. Epub 2009 Apr 24.

DOI:10.1038/modpathol.2009.66
PMID:19396148
Abstract

Stem cell markers, OCT3/4, and more recently SOX2 and growth differentiation factor 3 (GDF3), have been reported to be expressed variably in germ cell tumors. We investigated the immunohistochemical expression of these markers in different testicular germ cell tumors, and their utility in the differential diagnosis of morphologically difficult-to-classify components of these tumors. A total of 50 mixed testicular germ cell tumors, 43 also containing difficult-to-classify areas, were studied. In these areas, multiple morphological parameters were noted, and high-grade nuclear details similar to typical embryonal carcinoma were considered 'embryonal carcinoma-like high-grade'. Immunohistochemical staining for OCT3/4, c-kit, CD30, SOX2, and GDF3 was performed and graded in each component as 0, negative; 1+, 1-25%; 2+, 26-50%; and 3+, >50% positive staining cells. The different components identified in these tumors were seminoma (8), embryonal carcinoma (50), yolk sac tumor (40), teratoma (40), choriocarcinoma (3) and intra-tubular germ cell neoplasia, unclassified (35). By immunohistochemistry, the staining patterns were OCT3/4 -3+, all seminomas, embryonal carcinomas and intra-tubular germ cell neoplasia; SOX2 -3+, all embryonal carcinomas and -2 to 3+, 11/14 (79%) primitive neuroectodermal components in immature teratomas; GDF3 -2 to 3+, all yolk sac tumors, seminomas and intra-tubular germ cell neoplasia and 1 to 2+, 40/50 embryonal carcinomas. A total of 34/43 (79%) of difficult-to-classify areas stained 3+ for OCT3/4, CD30, and SOX2, similar to embryonal carcinoma. Among these areas, only 'embryonal carcinoma-like high-grade' nuclear details were significantly associated with such an immunophenotype. Thus, SOX2 is expressed in embryonal carcinoma and primitive neuroectoderm of teratoma, and unlike OCT3/4, not in intra-tubular germ cell neoplasia and seminoma. Therefore, it may be useful in the distinction of seminoma from embryonal carcinoma, and potentially in diagnosing early carcinomatous differentiation in seminoma. GDF3 positivity, in the absence of OCT3/4 and CD30, combined with morphological features, is helpful in the diagnosis of yolk sac tumor. 'Embryonal carcinoma-like high-grade' nuclear details are the most important morphological criterion for the diagnosis of embryonal carcinoma in difficult-to-classify areas.

摘要

干细胞标志物OCT3/4,以及最近发现的SOX2和生长分化因子3(GDF3),据报道在生殖细胞肿瘤中表达情况各异。我们研究了这些标志物在不同睾丸生殖细胞肿瘤中的免疫组化表达情况,以及它们在鉴别诊断这些肿瘤中形态学上难以分类的成分方面的效用。共研究了50例混合性睾丸生殖细胞肿瘤,其中43例还包含难以分类的区域。在这些区域,记录了多个形态学参数,与典型胚胎癌相似的高级别核细节被视为“胚胎癌样高级别”。对OCT3/4、c-kit、CD30、SOX2和GDF3进行免疫组化染色,并对每个成分按0级(阴性)、1+级(1 - 25%阳性染色细胞)、2+级(26 - 50%阳性染色细胞)和3+级(>50%阳性染色细胞)进行分级。这些肿瘤中鉴定出的不同成分包括精原细胞瘤(8例)、胚胎癌(50例)、卵黄囊瘤(40例)、畸胎瘤(40例)、绒毛膜癌(3例)和未分类的管内生殖细胞肿瘤(35例)。通过免疫组化,染色模式为:OCT3/4 - 3+,所有精原细胞瘤、胚胎癌和管内生殖细胞肿瘤;SOX2 - 3+,所有胚胎癌,以及 - 2至3+,11/14(79%)未成熟畸胎瘤中的原始神经外胚层成分;GDF3 - 2至3+,所有卵黄囊瘤、精原细胞瘤和管内生殖细胞肿瘤,以及1至2+,40/50胚胎癌。43例中有34例(79%)难以分类的区域OCT3/4、CD30和SOX2染色为3+,与胚胎癌相似。在这些区域中,只有“胚胎癌样高级别”核细节与这种免疫表型显著相关。因此,SOX2在胚胎癌和畸胎瘤的原始神经外胚层中表达,与OCT3/4不同,在管内生殖细胞肿瘤和精原细胞瘤中不表达。因此,它可能有助于区分精原细胞瘤和胚胎癌,并可能有助于诊断精原细胞瘤中的早期癌性分化。在没有OCT3/4和CD30的情况下,GDF3阳性结合形态学特征有助于卵黄囊瘤的诊断。“胚胎癌样高级别”核细节是在难以分类的区域诊断胚胎癌的最重要形态学标准。

相似文献

1
Testicular mixed germ cell tumors: a morphological and immunohistochemical study using stem cell markers, OCT3/4, SOX2 and GDF3, with emphasis on morphologically difficult-to-classify areas.睾丸混合性生殖细胞肿瘤:一项使用干细胞标志物OCT3/4、SOX2和GDF3的形态学和免疫组织化学研究,重点关注形态学上难以分类的区域。
Mod Pathol. 2009 Aug;22(8):1066-74. doi: 10.1038/modpathol.2009.66. Epub 2009 Apr 24.
2
Germ cell tumors of the gonads: a selective review emphasizing problems in differential diagnosis, newly appreciated, and controversial issues.性腺生殖细胞肿瘤:一篇选择性综述,重点强调鉴别诊断中的问题、新认识的问题及有争议的问题。
Mod Pathol. 2005 Feb;18 Suppl 2:S61-79. doi: 10.1038/modpathol.3800310.
3
Embryonic stem cell transcription factors and D2-40 (podoplanin) as diagnostic immunohistochemical markers in ovarian germ cell tumors.胚胎干细胞转录因子和D2-40(血小板内皮细胞黏附分子)作为卵巢生殖细胞肿瘤诊断的免疫组织化学标志物
Int J Gynecol Pathol. 2009 Jul;28(4):347-55. doi: 10.1097/PGP.0b013e318195da86.
4
D2-40 immunohistochemistry in the differential diagnosis of seminoma and embryonal carcinoma: a comparative immunohistochemical study with KIT (CD117) and CD30.D2-40免疫组织化学在精原细胞瘤和胚胎性癌鉴别诊断中的应用:与KIT(CD117)和CD30的免疫组织化学对比研究
Mod Pathol. 2007 Mar;20(3):320-5. doi: 10.1038/modpathol.3800749. Epub 2007 Feb 2.
5
Embryonic stem cell transcription factor signatures in the diagnosis of primary and metastatic germ cell tumors.胚胎干细胞转录因子特征在原发性和转移性生殖细胞肿瘤诊断中的应用
Am J Surg Pathol. 2007 Jun;31(6):836-45. doi: 10.1097/PAS.0b013e31802e708a.
6
OCT4 staining in testicular tumors: a sensitive and specific marker for seminoma and embryonal carcinoma.睾丸肿瘤中的OCT4染色:精原细胞瘤和胚胎性癌的敏感且特异标志物
Am J Surg Pathol. 2004 Jul;28(7):935-40. doi: 10.1097/00000478-200407000-00014.
7
Differential expression of SOX2 and SOX17 in testicular germ cell tumors.SOX2和SOX17在睾丸生殖细胞肿瘤中的差异表达。
Am J Clin Pathol. 2009 May;131(5):731-6. doi: 10.1309/AJCP7MNCNBCRN8NO.
8
Expression and interdependencies of pluripotency factors LIN28, OCT3/4, NANOG and SOX2 in human testicular germ cells and tumours of the testis.多能性因子LIN28、OCT3/4、NANOG和SOX2在人类睾丸生殖细胞及睾丸肿瘤中的表达及相互依赖性
Int J Androl. 2011 Aug;34(4 Pt 2):e160-74. doi: 10.1111/j.1365-2605.2011.01148.x. Epub 2011 Jun 2.
9
Wnt suppressor and stem cell regulator TCF7L1 is a sensitive immunohistochemical marker to differentiate testicular seminoma from non-seminomatous germ cell tumor.Wnt 抑制因子和干细胞调节因子 TCF7L1 是一种敏感的免疫组织化学标志物,可用于区分睾丸精原细胞瘤与非精原细胞瘤生殖细胞肿瘤。
Exp Mol Pathol. 2019 Oct;110:104293. doi: 10.1016/j.yexmp.2019.104293. Epub 2019 Aug 2.
10
Trials of new germ cell immunohistochemical stains in 93 extragonadal and metastatic germ cell tumors.93例性腺外和转移性生殖细胞肿瘤的新型生殖细胞免疫组织化学染色试验
Hum Pathol. 2008 Feb;39(2):275-81. doi: 10.1016/j.humpath.2007.07.002. Epub 2007 Nov 28.

引用本文的文献

1
A multi-analyte liquid biopsy approach for nonseminomatous testicular germ cell tumors: combining cfDNA and N-glycan analysis in blood and seminal plasma.一种用于非精原性睾丸生殖细胞肿瘤的多分析物液体活检方法:结合血液和精浆中的cfDNA和N-聚糖分析
Cancer Cell Int. 2025 Jul 11;25(1):257. doi: 10.1186/s12935-025-03887-8.
2
Testicular Germ Cell Tumor Tissue Biomarker Analysis: A Comparison of Human Protein Atlas and Individual Testicular Germ Cell Tumor Component Immunohistochemistry.睾丸生殖细胞肿瘤组织生物标志物分析:人类蛋白质图谱与单个睾丸生殖细胞肿瘤成分免疫组织化学的比较。
Cells. 2023 Jul 13;12(14):1841. doi: 10.3390/cells12141841.
3
Epigenetic Regulation of Driver Genes in Testicular Tumorigenesis.
表观遗传调控睾丸肿瘤发生中的驱动基因。
Int J Mol Sci. 2023 Feb 19;24(4):4148. doi: 10.3390/ijms24044148.
4
Absent Testis With a Mediastinal Germ Cell Tumor.隐睾合并纵隔生殖细胞肿瘤。
Cureus. 2022 Apr 25;14(4):e24472. doi: 10.7759/cureus.24472. eCollection 2022 Apr.
5
The core four - A panel of immunohistochemistry markers to diagnose and subtype testicular germ cell tumors.核心四联——用于诊断和对睾丸生殖细胞肿瘤进行亚型分类的一组免疫组织化学标志物。
Urol Ann. 2022 Jan-Mar;14(1):21-26. doi: 10.4103/ua.ua_69_21. Epub 2021 Dec 28.
6
Phase II trial of brentuximab vedotin in relapsed/refractory germ cell tumors.Ⅱ期临床试验评估 Brentuximab vedotin 在复发/难治性生殖细胞肿瘤中的疗效。
Invest New Drugs. 2021 Dec;39(6):1656-1663. doi: 10.1007/s10637-021-01134-1. Epub 2021 May 24.
7
Lack of expression of ALK and CD30 in breast carcinoma by immunohistochemistry irrespective of tumor characteristics.无论肿瘤特征如何,通过免疫组织化学检测,乳腺癌中ALK和CD30均无表达。
Medicine (Baltimore). 2019 Aug;98(32):e16702. doi: 10.1097/MD.0000000000016702.
8
Assessment of established techniques to determine developmental and malignant potential of human pluripotent stem cells.评估已建立的技术以确定人类多能干细胞的发育和恶性潜能。
Nat Commun. 2018 May 15;9(1):1925. doi: 10.1038/s41467-018-04011-3.
9
Brentuximab vedotin exerts profound antiproliferative and pro-apoptotic efficacy in CD30-positive as well as cocultured CD30-negative germ cell tumour cell lines.本妥昔单抗维迪昔单抗在 CD30 阳性和共培养的 CD30 阴性生殖细胞瘤细胞系中均表现出显著的抗增殖和促凋亡作用。
J Cell Mol Med. 2018 Jan;22(1):568-575. doi: 10.1111/jcmm.13344. Epub 2017 Sep 22.
10
The primitive extratesticular seminoma: diagnosis of a rare pathology.原发性睾丸外精原细胞瘤:一种罕见病理类型的诊断
Acta Biomed. 2017 Apr 28;88(1):82-85. doi: 10.23750/abm.v88i1.5601.